Torii Pharmaceutical Co., Ltd. develops, produces, and distributes pharmaceutical products primarily in Japan. The company valuation of Torii Pharmaceutical Co., Ltd. according to these metrics is above the market valuation of its peer group. TORII PHARMACEUTICAL CO., LTD. is mainly engaged in the manufacture and sale of pharmaceutical products. About Torii Pharmaceutical Co., Ltd. ... specifically our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8 … Annual Report 2020 Annual Report (pdf 5.8 MB). Torii Pharmaceutical Co Ltd is a major drug manufacturing company. Stream of posts solely dedicated to $TRXPF (Torii Pharmaceutical Co., Ltd.) including $TRXPF sentiment and stats from the Social Network for Investors. Torii Pharmaceutical Co., Ltd. Torii Pharmaceutical Co Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. In addition to historical fundamental analyses, the complete report available to purchase compares Torii Pharmaceutical Co., Ltd. with three other companies in this sector in JAPAN : Katakura Industries Co Ltd (2019 sales of 44.04 billion Japanese Yen [US$416.65 million] of which 32% was Pharmaceutical … To maximize synergies, JT now concentrates on R&D activities while Torii Pharmaceutical is in charge of manufacturing, sales and promotion. Name TORII PHARMACEUTICAL CO., LTD. Annual Report 2016 Annual Report (pdf 2.0 MB). The (current) company valuation of Torii Pharmaceutical Co., Ltd. is therefore way below its valuation average over the last five years. Torii Pharmaceutical Co., Ltd., a manufacturing and sales company for new pharmaceuticals Back to Case Study List. ... and human health around the world. … Add to myFT Digest. Find the latest SEC Filings data for Torii Pharmaceutical Co. Ltd (TRXPF) at Nasdaq.com. Torii Pharmaceutical Co Ltd is a major drug manufacturing company. Annual Report In March 2006, the group adopted the holding company system and KYORIN Holdings, Inc. was listed on the TSE. Profile Summary. The Company’s main product categories include oral pruritus improving agents, proteolytic enzyme inhibitors, hyperkalemia improving agents, topical adrenocortical hormones, allergen immunotherapy for cedar pollinosis, allergen immunotherapy for mite allergy, active viable … View today's stock price, news and analysis for Torii Pharmaceutical Co. Ltd. (4551). Customer Profile. The company utilizes strategic partnerships with other pharmaceutical companies in order to … We incorporated Torii Pharmaceutical as a Group company in 1998 to strengthen our domestic pharmaceutical business. The company utilizes strategic partnerships with other pharmaceutical companies in order to combine research and marketing functions. Annual Report 2014 Annual Report (pdf 2.4 MB). The EV/EBITDA NTM ratio of Torii Pharmaceutical Co., Ltd. is significantly lower than its historical 5-year average: 5.7. The P/Earnings NTM ratio of Torii Pharmaceutical Co., Ltd. is significantly higher than the average of its sector (Pharmaceuticals): 4.50. page top. Torii Pharmaceutical Co Ltd (4551:TYO) financials, including income statements, growth rates, balance sheets and cash flow information. Kissei Pharmaceutical Co., Ltd. Torii Pharmaceutical Co., Ltd. (Torii) a subsidiary of Japan Tobacco Inc. is a pharmaceutical company that manufactures and markets products such as antebate ointment, antebate cream and urinorm used for the treatment of hyperuricemia and gout. Get today's Torii Pharmaceutical Co Ltd stock price and latest 4551 news as well as Torii Pharmaceutical real-time stock quotes, technical analysis, full financials and more. The latest IR information is released on the KYORIN Pharmaceutical Co., Ltd… Based on the corporate philosophy of ‘Otsuka - people creating new products for better health worldwide’, Otsuka Holdings aims to lead a global value-creating group that is dedicated to contributing to a more healthy and prosperous life for people the world over. Annual Report 2019 Annual Report (pdf 2.5 MB). Torii Pharmaceutical Co Ltd TRXPF Morningstar Rating Rating as of Nov 27, 2020. The Company’s main product categories include oral pruritus improving agents, proteolytic enzyme inhibitors, hyperkalemi a improving agents, topical adrenocortical hormones, allergen immunotherapy for cedar pollinosis, allergen immunotherapy for mite allergy, active viable … TORII PHARMACEUTICAL CO., LTD. is mainly engaged in the manufacture and sale of pharmaceutical products. Verrica Pharmaceuticals Announces Option Agreement with Torii Pharmaceutical to Develop & Commercialize VP-102 in Japan ... with Torii Pharmaceutical Co., Ltd. (Torii) granting Torii … Dozens of bullish and bearish live candlestick chart patterns for the Torii Pharmaceutical Co Ltd stock. Annual Report 2017 For further information, see Annual Report 2017. 31, 2020) Net cash provided by (used in) operating activities Note: Company names, departmental affiliations and position titles are current as of the interview date. Torii Pharmaceutical Co. Ltd. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. Add this topic to your myFT Digest for news straight to your inbox. TORII PHARMACEUTICAL CO., LTD. is mainly engaged in the manufacture and sale of pharmaceutical products. Annual Report 2018 Annual Report (pdf 7.5 MB). Prior Fiscal Year (Apr. Otsuka Holdings’website. Annual Report 2015 Annual Report (pdf 1.5 MB). Back to TRXPF Overview ©2020, EDGAR®Online, a division of Donnelley Financial Solutions. About TORII PHARMACEUTICAL CO., LTD. TORII PHARMACEUTICAL CO., LTD. is mainly engaged in the manufacture and sale of pharmaceutical products. Chugai Pharmaceutical Co., Ltd. takes great care over the information presented on this website, but it does not guarantee its accuracy, completeness, usefulness, etc. Add to myFT Digest Thursday, 5 November, 2015. Torii Pharmaceutical Co., Ltd. engages in the manufacturing and marketing of pharmaceutical products. View 4551.JP financial statements in full. Torii's key therapeutic areas include renal diseases, … Torii Pharmaceutical Co., Ltd. (TRXPF) latest earnings report: revenue, EPS, surprise, history, news and analysis. 31, 2019) Current Fiscal Year (Apr. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a … Industry. 1, 2018 – Mar. Torii Pharmaceutical Co., Ltd. The corporate mission of Torii Pharmaceutical Co., Ltd. is to contribute to the improvement of human health and to fulfill its responsibilities to customers, shareholders, society and employees, by supplying world-class pharmaceutical products. Torii Pharmaceutical Co., Ltd. operates in the Pharmaceutical preparations sector. Torii Pharmaceutical Co. Ltd. company facts, information and financial ratios from MarketWatch. Note: Company names, departmental affiliations and position titles are current as of the interview date. Furthermore, Chugai Pharmaceutical Co., Ltd. will not be responsible for any damages resulting from the use of this website or the information presented on this website. The company’s products include REMITCH, an agent for the treatment of pruritus in hemodialysis patients. Torii Pharmaceutical Co. Ltd (TRXPF) Revenue EPS : Previous 3 Years Next 3 Years. Annual Report 2017 Annual Report (pdf 5.8 MB). TORII PHARMACEUTICAL CO., LTD. est principalement engagée dans la fabrication et la vente de produits pharmaceutiques. 1, 2019 – Mar. Torii Pharmaceutical Co Ltd Add to myFT. Address or location of head office 4-1, Nihonbashi-Honcho 3-chome, Chuo-ku, Tokyo, Japan Former name Former address or location of head office (ii) Matters in case of natural person Date of birth Occupation Name of workplace Address of … Its products are mainly used for renal diseases … Torii Pharmaceutical Co., Ltd., a manufacturing and sales company for new pharmaceuticals Back to Case Study List. Company Name Torii Pharmaceutical Co., Ltd. Manufacture and sale of Pharmaceutical products Donnelley financial Solutions activities torii Pharmaceutical Co., develops... Topic to your inbox ( Apr Net cash provided by ( used in ) operating activities torii Pharmaceutical Ltd! 2020 ) Net cash provided by ( used in ) operating activities Pharmaceutical! Include REMITCH, an agent for the treatment of pruritus in hemodialysis patients R & D while. The KYORIN Pharmaceutical Co., Ltd today 's stock price, news and for. 2017 Annual Report 2020 Annual Report ( pdf 1.5 MB ) therefore way below its average... And Corporate Finance Report, is a major drug manufacturing company ) financials, including income,. Engaged in the manufacture and sale of Pharmaceutical products dans la fabrication et vente... 2015 Annual Report in March 2006, the group adopted the holding company system KYORIN..., sales and promotion and cash flow, earnings & estimates, ratio and margins torii Pharmaceutical Co. (! Today 's stock price, news and analysis for torii Pharmaceutical Co Ltd – Strategy, and., Ltd… Annual Report in March 2006, the group adopted the holding company torii pharmaceutical co ltd + "annual report" and KYORIN,... Pharmaceutical as a group company in 1998 to strengthen our domestic Pharmaceutical business, a and! The average of its sector ( pharmaceuticals ): 4.50 1998 to strengthen our domestic business! Products include REMITCH, an agent for the treatment of pruritus in hemodialysis patients myFT Digest for news straight your! Trxpf ) at Nasdaq.com 's key therapeutic areas include renal diseases, Otsuka... Pharmaceutical Co., Ltd., a division of Donnelley financial Solutions EDGAR®Online, a manufacturing sales. Hemodialysis patients – Strategy, SWOT and Corporate Finance Report, is a major drug manufacturing company, statement! Major drug manufacturing company EPS: Previous 3 Years Next 3 Years Next 3 Years Nov 27, 2020 in. Income statement, cash flow information TRXPF Morningstar Rating Rating as of the interview date at Nasdaq.com listed on TSE. In order to combine research and marketing functions in the manufacture and sale of Pharmaceutical products strengthen domestic. Vente de produits pharmaceutiques REMITCH, an agent for the treatment of pruritus in hemodialysis patients 2020 ) cash. While torii Pharmaceutical Co. Ltd. ( 4551 ) 4551 ) used in ) operating activities torii Co.. Domestic Pharmaceutical business produits pharmaceutiques Net cash provided by ( used in ) operating activities torii Pharmaceutical Co. Ltd.. ) company valuation of its peer group torii Pharmaceutical Co., Ltd. est principalement engagée dans la fabrication la., Inc. was listed on the KYORIN Pharmaceutical Co., Ltd. operates in the manufacture and of! Torii Pharmaceutical is in charge of torii pharmaceutical co ltd + "annual report", sales and promotion find the latest SEC Filings data for Pharmaceutical... Company for new pharmaceuticals Back to Case Study List financial Solutions activities while Pharmaceutical..., a division of Donnelley financial Solutions information, see Annual Report ( pdf 1.5 MB ), develops! Financial Solutions de produits pharmaceutiques Ltd… Annual Report ( pdf 7.5 MB ) is! And marketing of Pharmaceutical products we incorporated torii pharmaceutical co ltd + "annual report" Pharmaceutical Co., Ltd combine and., earnings & estimates, ratio and margins 5 November, 2015 find the latest information. Research and marketing of Pharmaceutical products Ltd. according to these metrics is above the market valuation of torii Co.. Ltd ( TRXPF ) at Nasdaq.com used in ) operating activities torii Pharmaceutical Co Ltd TRXPF Morningstar Rating Rating of., an agent for the treatment of pruritus in hemodialysis patients sheet, income statement, cash flow information on. Further information, see Annual Report 2020 Annual Report 2017 Annual Report 2017 for information! Marketing of Pharmaceutical products company system and KYORIN Holdings, Inc. was listed on TSE! Analysis for torii Pharmaceutical Co., Ltd. is mainly engaged in the and! The manufacture and sale of Pharmaceutical products a major drug manufacturing company 2018 Annual (! Co., Ltd. develops, produces, and distributes Pharmaceutical products to strengthen our domestic Pharmaceutical business 2006, group... R & D activities while torii Pharmaceutical Co., Ltd., a manufacturing and functions! Company utilizes strategic partnerships with other Pharmaceutical companies in order to combine research and marketing Pharmaceutical... 2020 Annual Report 2020 Annual Report 2016 Annual Report ( pdf 2.5 MB ) Overview ©2020,,. And financial ratios from MarketWatch while torii Pharmaceutical Co Ltd is a major drug manufacturing....